Note this is a video recording of an online meeting conducted using the Zoom.us platform. Inevitably such recordings suffer a little in terms of their production values because of the internet connectivity and quality of webcams. Despite that, they allow us to provide additional valuable insights in to the MedComms business and we can involve a wider range of speakers who can participate from the comfort of their own desks, wherever in the world they are.

With more and more pharmaceutical companies putting patient centricity at the forefront of drug development, the role of the patient in clinical research has undergone huge transformation in recent years. But how far have we come in terms of ensuring the accessibility – to patients – of the information this research generates, and will GPP 2022 help us make more progress towards meeting the information needs of today’s patients? In this webinar we are joined by Jamil Rivers, METAvivor Research & Support, Jenny Ghith, Senior Director, Omnichannel Strategy and Innovation Lead, Global Scientific Communications at Pfizer, Caroline Shepherd, Portfolio Director and Helena Williams, Head of Medical Services at CMC Connect to answer these questions, from both the industry and the patient perspective. And we answer questions from the audience.

Recorded 26 October 2022 as a MedComms Networking webinar. Produced by NetworkPharma.tv

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

Jamil’s web page is at https://thechrysalisinitiative.org/our-founder/

Jenny’s LinkedIn page is at https://www.linkedin.com/in/jennyghith/

Caroline’s LinkedIn page is at https://www.linkedin.com/in/caroline-shepherd-2439b27/

Helena’s LinkedIn page is at https://www.linkedin.com/in/helena-williams-6b13b11a/

Find out more about METAvivor at https://www.metavivor.org/about-us/

Find out more about CMC Connect at https://connect-cmc.com/

Find out more about Pfizer at https://www.pfizer.com/

Further reading

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update
See https://www.acpjournals.org/doi/10.7326/M22-1460

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =  = = = = = = = = = = = = = =

We are building a library of free webcasts and other video content for the global MedComms Community and others at http://www.networkpharma.tv and we’d welcome your suggestions for new content.

[For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like. Cheers Peter Llewellyn, Director NetworkPharma Ltd and Founder of the MedComms Networking Community activity at http://www.medcommsnetworking.com]